{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:06:25Z","timestamp":1778198785247,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Open Research Program of Xiangyang Central Hospital","award":["2023NB102"],"award-info":[{"award-number":["2023NB102"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82303050"],"award-info":[{"award-number":["82303050"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hubei Provincial Natural Science Foundation of China general project","award":["2025AFB942"],"award-info":[{"award-number":["2025AFB942"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04623-5","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:34:23Z","timestamp":1767965663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Urinary proteomic profiling reveals diagnostic biomarkers and regulatory networks in myasthenia gravis"],"prefix":"10.1186","volume":"26","author":[{"given":"Jing","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-kun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-ge","family":"San","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianchen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"issue":"10","key":"4623_CR1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015;14(10):1023\u201336.","journal-title":"Lancet Neurol"},{"issue":"26","key":"4623_CR2","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","volume":"375","author":"NE Gilhus","year":"2016","unstructured":"Gilhus NE. Myasthenia Gravis. N Engl J Med. 2016;375(26):2570\u201381.","journal-title":"N Engl J Med"},{"key":"4623_CR3","first-page":"e8497","volume":"345","author":"J Spillane","year":"2012","unstructured":"Spillane J, Higham E, Kullmann DM. Myasthenia Gravis. BMJ (Clinical Res ed). 2012;345:e8497.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"38","key":"4623_CR4","doi-asserted-by":"publisher","first-page":"E1141","DOI":"10.1503\/cmaj.180656","volume":"190","author":"P Bourque","year":"2018","unstructured":"Bourque P, Breiner A. Myasthenia Gravis. CMAJ: Can Med Association J. 2018;190(38):E1141.","journal-title":"CMAJ: Can Med Association J"},{"key":"4623_CR5","doi-asserted-by":"publisher","first-page":"1404191","DOI":"10.3389\/fimmu.2024.1404191","volume":"15","author":"P Cavalcante","year":"2024","unstructured":"Cavalcante P, Mantegazza R, Antozzi C. Targeting autoimmune mechanisms by precision medicine in myasthenia Gravis. Front Immunol. 2024;15:1404191.","journal-title":"Front Immunol"},{"key":"4623_CR6","volume-title":"CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis","author":"F Fischbach","year":"2024","unstructured":"Fischbach F, Richter J, Pfeffer LK, Fehse B, Berger SC, Reinhardt S, et al. CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis. Volume 5. New York, NY): Med; 2024. 6."},{"issue":"2","key":"4623_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1474-4422(21)00297-0","volume":"21","author":"AR Punga","year":"2022","unstructured":"Punga AR, Maddison P, Heckmann JM, Guptill JT, Evoli A. Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders. Lancet Neurol. 2022;21(2):176\u201388.","journal-title":"Lancet Neurol"},{"key":"4623_CR8","doi-asserted-by":"crossref","unstructured":"Kaminski HJ, Sikorski P, Coronel SI, Kusner LL. Myasthenia gravis: the future is here. J Clin Investig. 2024;134(12):e179742.","DOI":"10.1172\/JCI179742"},{"issue":"39","key":"4623_CR9","doi-asserted-by":"publisher","first-page":"e2408324121","DOI":"10.1073\/pnas.2408324121","volume":"121","author":"J Oury","year":"2024","unstructured":"Oury J, Gamallo-Lana B, Santana L, Steyaert C, Vergoossen DLE, Mar AC, et al. Agonist antibody to musk protects mice from musk myasthenia Gravis. Proc Natl Acad Sci USA. 2024;121(39):e2408324121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4623_CR10","doi-asserted-by":"crossref","unstructured":"Akshintala VS, Moore MG, Cruz-Monserrate Z, Nathan JD, Searle BC, Abu-El-Haija M. Urine proteomics profiling identifies novel acute pancreatitis diagnostic biomarkers in a pediatric population. Gastroenterology. 2024;167(5):1019\u20131021.e2.","DOI":"10.1053\/j.gastro.2024.05.015"},{"key":"4623_CR11","first-page":"829","volume-title":"Urine proteomics and renal Single-Cell transcriptomics implicate Interleukin-16 in lupus nephritis","author":"A Fava","year":"2022","unstructured":"Fava A, Rao DA, Mohan C, Zhang T, Rosenberg A, Fenaroli P, et al. Urine proteomics and renal Single-Cell transcriptomics implicate Interleukin-16 in lupus nephritis. Volume 74. Hoboken, NJ: Arthritis & Rheumatology; 2022. pp. 829\u201339. 5."},{"key":"4623_CR12","doi-asserted-by":"publisher","first-page":"102736","DOI":"10.1016\/j.arr.2025.102736","volume":"108","author":"MR Afrin","year":"2025","unstructured":"Afrin MR, Upadhyaya PG, Hashim A, Bhattacharya K, Chanu NR, Das D, et al. Advanced biomarkers: beyond amyloid and tau: emerging non-traditional biomarkers for alzheimer`s diagnosis and progression. Ageing Res Rev. 2025;108:102736.","journal-title":"Ageing Res Rev"},{"key":"4623_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ebiom.2019.06.021","volume":"45","author":"S Wang","year":"2019","unstructured":"Wang S, Kojima K, Mobley JA, West AB. Proteomic analysis of urinary extracellular vesicles reveal biomarkers for neurologic disease. EBioMedicine. 2019;45:351\u201361.","journal-title":"EBioMedicine"},{"key":"4623_CR14","doi-asserted-by":"crossref","unstructured":"Fava A, Buyon J, Magder L, Hodgin J, Rosenberg A, Demeke DS et al. Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis. JCI Insight. 2024;9(2):e172569.","DOI":"10.1172\/jci.insight.172569"},{"issue":"1","key":"4623_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s43657-023-00125-x","volume":"4","author":"Q Ji","year":"2024","unstructured":"Ji Q, Jiang X, Wang M, Xin Z, Zhang W, Qu J, et al. Multimodal omics approaches to aging and Age-Related diseases. Phenomics (Cham Switzerland). 2024;4(1):56\u201371.","journal-title":"Phenomics (Cham Switzerland)"},{"key":"4623_CR16","doi-asserted-by":"crossref","unstructured":"Ying W. Phenomic Studies on Diseases: Potential and Challenges. Phenomics (Cham, Switzerland) 2023;3(3):285\u2013299.","DOI":"10.1007\/s43657-022-00089-4"},{"issue":"4","key":"4623_CR17","doi-asserted-by":"publisher","first-page":"e20230016","DOI":"10.1002\/INMD.20230016","volume":"1","author":"Y Huang","year":"2023","unstructured":"Huang Y, Arab T, Russell AE, Mallick ER, Nagaraj R, Gizzie E, et al. Toward a human brain extracellular vesicle atlas: characteristics of extracellular vesicles from different brain regions, including small RNA and protein profiles. Interdisciplinary Med. 2023;1(4):e20230016.","journal-title":"Interdisciplinary Med"},{"issue":"8085","key":"4623_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0140-6736(78)92960-4","volume":"2","author":"BT Adornato","year":"1978","unstructured":"Adornato BT, Houff SA, Engel WK, Dalakas M, Madden DL, Sever JL. Abnormal Immunoglobulin bands in cerebrospinal fluid in myasthenia Gravis. Lancet (London England). 1978;2(8085):367\u20138.","journal-title":"Lancet (London England)"},{"issue":"2","key":"4623_CR19","doi-asserted-by":"publisher","first-page":"e14568","DOI":"10.1111\/cns.14568","volume":"30","author":"M Su","year":"2024","unstructured":"Su M, Luo Q, Wu Z, Feng H, Zhou H. Thymoma-associated autoimmune encephalitis with myasthenia gravis: case series and literature review. CNS Neurosci Ther. 2024;30(2):e14568.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"4623_CR20","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1038\/s41467-022-30391-8","volume":"13","author":"Y Sun","year":"2022","unstructured":"Sun Y, Guo Z, Liu X, Yang L, Jing Z, Cai M, et al. Noninvasive urinary protein signatures associated with colorectal cancer diagnosis and metastasis. Nat Commun. 2022;13(1):2757.","journal-title":"Nat Commun"},{"issue":"6","key":"4623_CR21","doi-asserted-by":"publisher","first-page":"e56282","DOI":"10.15252\/embr.202256282","volume":"24","author":"K Meng","year":"2023","unstructured":"Meng K, Lu S, Li Y-Y, Hu L-L, Zhang J, Cao Y, et al. LINC00493-encoded microprotein SMIM26 exerts anti-metastatic activity in renal cell carcinoma. EMBO Rep. 2023;24(6):e56282.","journal-title":"EMBO Rep"},{"issue":"3","key":"4623_CR22","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1021\/acs.jproteome.9b00800","volume":"19","author":"K Meng","year":"2020","unstructured":"Meng K, Lu S, Yan X, Sun Y, Gao J, Wang Y, et al. Quantitative mitochondrial proteomics reveals ANXA7 as a crucial factor in mitophagy. J Proteome Res. 2020;19(3):1275\u201384.","journal-title":"J Proteome Res"},{"issue":"1","key":"4623_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41392-025-02128-8","volume":"10","author":"K Meng","year":"2025","unstructured":"Meng K, Li Y, Yuan X, Shen H-M, Hu L-L, Liu D, et al. The cryptic lncRNA-encoded microprotein TPM3P9 drives oncogenic RNA splicing and tumorigenesis. Signal Transduct Target Ther. 2025;10(1):43.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"4623_CR24","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","volume":"8","author":"MN Meriggioli","year":"2009","unstructured":"Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol. 2009;8(5):475\u201390.","journal-title":"Lancet Neurol"},{"issue":"11","key":"4623_CR25","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1172\/JCI29894","volume":"116","author":"BM Conti-Fine","year":"2006","unstructured":"Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis: past, present, and future. J Clin Investig. 2006;116(11):2843\u201354.","journal-title":"J Clin Investig"},{"issue":"5","key":"4623_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","volume":"12","author":"NE Gilhus","year":"2016","unstructured":"Gilhus NE, Skeie GO, Romi F, Lazaridis K, Zisimopoulou P, Tzartos S. Myasthenia gravis - autoantibody characteristics and their implications for therapy. Nat Reviews Neurol. 2016;12(5):259\u201368.","journal-title":"Nat Reviews Neurol"},{"issue":"23","key":"4623_CR27","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.1038\/s41388-021-01827-0","volume":"40","author":"X-L Zhang","year":"2021","unstructured":"Zhang X-L, Hu L-P, Yang Q, Qin W-T, Wang X, Xu C-J, et al. CTHRC1 promotes liver metastasis by reshaping infiltrated macrophages through physical interactions with TGF-\u03b2 receptors in colorectal cancer. Oncogene. 2021;40(23):3959\u201373.","journal-title":"Oncogene"},{"issue":"5","key":"4623_CR28","doi-asserted-by":"publisher","first-page":"e15535","DOI":"10.1016\/j.heliyon.2023.e15535","volume":"9","author":"X Wang","year":"2023","unstructured":"Wang X, Zhang Y, Song N, Li K, Lei S, Wang J, et al. CILP2: A prognostic biomarker associated with immune infiltration in colorectal cancer. Heliyon. 2023;9(5):e15535.","journal-title":"Heliyon"},{"key":"4623_CR29","doi-asserted-by":"crossref","unstructured":"Schloesser D, Lindenthal L, Sauer J, Chung K-J, Chavakis T, Griesser E et al. Senescent cells suppress macrophage-mediated corpse removal via upregulation of the CD47-QPCT\/L axis. J Cell Biol 2023;222(2).","DOI":"10.1083\/jcb.202207097"},{"issue":"3","key":"4623_CR30","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s00018-022-04182-9","volume":"79","author":"S Mishra","year":"2022","unstructured":"Mishra S, Knupp A, Szabo MP, Williams CA, Kinoshita C, Hailey DW, et al. The alzheimer\u2019s gene SORL1 is a regulator of endosomal traffic and recycling in human neurons. Cell Mol Life Sci. 2022;79(3):162.","journal-title":"Cell Mol Life Sci"},{"key":"4623_CR31","doi-asserted-by":"crossref","unstructured":"Dan W, Fan Y, Wang Y, Hou T, Wei Y, Liu B et al. The Tumor Suppressor TPD52-Governed Endoplasmic Reticulum Stress is Modulated by APCCdc20. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 2024;11(45):e2405441.","DOI":"10.1002\/advs.202405441"},{"issue":"1","key":"4623_CR32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1158\/1078-0432.CCR-21-2057","volume":"28","author":"A Delaidelli","year":"2022","unstructured":"Delaidelli A, Dunham C, Santi M, Negri GL, Triscott J, Zheludkova O, et al. Clinically tractable outcome prediction of Non-WNT\/Non-SHH Medulloblastoma based on TPD52 IHC in a multicohort study. Clin Cancer Research: Official J Am Association Cancer Res. 2022;28(1):116\u201328.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"5","key":"4623_CR33","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1038\/s44319-024-00117-6","volume":"25","author":"P Kaminska","year":"2024","unstructured":"Kaminska P, Ovesen PL, Jakiel M, Obrebski T, Schmidt V, Draminski M, et al. SorLA restricts TNF\u03b1 release from microglia to shape a glioma-supportive brain microenvironment. EMBO Rep. 2024;25(5):2278\u2013305.","journal-title":"EMBO Rep"},{"issue":"2","key":"4623_CR34","doi-asserted-by":"publisher","first-page":"166965","DOI":"10.1016\/j.bbadis.2023.166965","volume":"1870","author":"K Shi","year":"2024","unstructured":"Shi K, Zhou J, Li M, Yan W, Zhang J, Zhang X, et al. Pan-cancer analysis of PLAU indicates its potential prognostic value and correlation with neutrophil infiltration in BLCA. Biochim Et Biophys Acta Mol Basis Disease. 2024;1870(2):166965.","journal-title":"Biochim Et Biophys Acta Mol Basis Disease"},{"issue":"1","key":"4623_CR35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s11658-024-00639-w","volume":"29","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang C, Xu Y, Su H. Tetraspanin 3 promotes NSCLC cell proliferation via regulation of \u03b21 integrin intracellular recycling. Cell Mol Biol Lett. 2024;29(1):124.","journal-title":"Cell Mol Biol Lett"},{"key":"4623_CR36","doi-asserted-by":"crossref","unstructured":"Fang Y, Wang L, Wan C, Sun Y, Van der Jeught K, Zhou Z et al. MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation. J Clin Investig. 2021;131(1):e140837.","DOI":"10.1172\/JCI140837"},{"key":"4623_CR37","doi-asserted-by":"crossref","unstructured":"Dersh D, Yewdell JW. Immune MAL2-practice: breast cancer immunoevasion via MHC class I degradation. J Clin Investig. 2021;131(1):e144344.","DOI":"10.1172\/JCI144344"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04623-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04623-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04623-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T14:50:29Z","timestamp":1770389429000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-025-04623-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4623"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04623-5","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted under the Declaration of Helsinki, and the study protocol was reviewed and approved by the Ethical Review Committee of the Xiangyang Central Hospital. Written informed consent was obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}